Oncocross

At a glance

Oncocross filed 51 disclosures in the last 12 months, including 7 5% holder, 4 insider, 1 issuance and 1 m&a. The most recent key filing was on Oct 8.

The 2025 annual report lists 40 employees with an average tenure of 1.6 years and average pay of ₩75.3M. Its 5 directors and auditors were paid ₩162.3M each on average. It paid no cash dividend for 2025. 김이랑 and related parties held 17.37% at year end.

From the 2025 annual report

Staff: 40 (28 men, 12 women), of whom 2 on fixed-term contracts. Total pay for the year: ₩2.4B. Directors and auditors: 5, paid ₩811.4M in total.

No cash dividend was paid for 2025.

Largest shareholder

김이랑 holds 17.06%; with 4 related parties the group holds 17.37% of common shares at year end (from 20.10% at the start of the year).

Auditor: 대주회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary